Immune+Tolerance+10_28_24

Immune Tolerance OverviewImmune tolerance is the state in which the immune system does not mount a response against self-antigens while remaining responsive to foreign antigens. This is crucial for preventing autoimmune diseases, wherein the immune system attacks the body's own tissues.

I. Central ToleranceCentral tolerance occurs primarily in primary lymphoid organs, such as the thymus and bone marrow. This process involves several mechanisms:

  1. Negative Selection: In the thymus, T cells that recognize self-antigens with high affinity are induced to undergo apoptosis, thus preventing the survival of potentially harmful self-reactive T cells.

  2. Receptor Editing: For B cells, this involves changing their B cell receptor (BCR) specificity to eliminate reactivity to self-antigens. If a B cell binds strongly to a self-antigen, it can undergo secondary rearrangement of its immunoglobulin genes to produce a different BCR that no longer reacts to that self-antigen.

  3. Development of Tregs: Regulatory T cells (Tregs) arise in the thymus and play a vital role in maintaining immune tolerance. They express the transcription factor FoxP3 and produce anti-inflammatory cytokines like IL-10 and TGF-β, making them essential for suppressing self-reactive T cells.

II. Peripheral TolerancePeripheral tolerance operates in secondary lymphoid organs, preventing self-reactive lymphocytes that escape central tolerance from becoming activated. Mechanisms include:

  1. Anergy: A state in which T cells become functionally inactive when they recognize their specific antigen without the necessary second signals usually provided by costimulatory molecules. Anergic T cells can survive but are rendered unresponsive.

  2. Deletion: This refers to the apoptosis of self-reactive T cells in the periphery upon repeated stimulation by self-antigens. It serves to curtail harmful immune responses.

  3. Suppression by Tregs or MDSCs: Tregs inhibit activation and proliferation of self-reactive T cells through direct cell-to-cell contact or the secretion of immunosuppressive factors. Myeloid-derived suppressor cells (MDSCs) also play a role in regulating immune responses, particularly in cancer and inflammatory conditions.

III. Role of TregsTregs are characterized by their expression of CD4, CD25, and the transcription factor FoxP3. They contribute to peripheral tolerance through:

  • Inhibiting dendritic cell maturation, leading to a reduced capacity to activate T cells.

  • Producing cytokines such as TGF-β, which promotes tolerance.

  • Engaging in metabolic disruption, which deprives other immune cells of nutrients required for activation and proliferation.

IV. Role of Costimulatory ReceptorsCostimulatory receptors, such as CTLA-4, play a critical role in peripheral tolerance. CTLA-4 is expressed on Tregs and activated T cells and acts as a negative regulator of T cell activation.

  • Upon binding to B7 molecules on APCs, CTLA-4 competes with the stimulatory receptor CD28. This competition helps to dampen T cell responses and is essential in preventing autoimmunity. Variants in the CTLA-4 gene are linked to several autoimmune conditions, indicating its importance in tolerance.

V. B Cell ToleranceB cell tolerance primarily occurs in the bone marrow and involves similar mechanisms to T cell tolerance.

  1. Central B Cell Tolerance: Self-reactive B cells that recognize autoantigens during their development can be eliminated through apoptosis or altered to decrease their affinity for self-antigens through receptor editing.

  2. Peripheral B Cell Tolerance: In the periphery, mechanisms can include: - Anergy, when B cells recognize self-antigens without T helper signals. - Deletion of activated self-reactive B cells to maintain homeostasis. - Expression of inhibitory receptors, such as CD22, which help restrain activation signals.

VI. Immune PrivilegeCertain organs, such as the eye, brain, and testes, demonstrate immune privilege, which limits immune responses to protect sensitive tissues. Mechanisms that support immune privilege include:

  • Formation of physical barriers (e.g., blood-brain barrier) to restrict immune cell access.

  • Low expression of MHC molecules on cells within these organs reduces the presentation of self-antigens to T cells.

  • Local production of cytokines that promote tolerance (e.g., IL-10).

  • Increased presence of Tregs that maintain a controlled immune environment and prevent inflammation.

Overall, both central and peripheral tolerance mechanisms are crucial for maintaining immune homeostasis and preventing autoimmunity. Understanding these processes can lead to better therapeutic strategies for autoimmunity and transplantation.